The aggrephagy-related gene TUBA1B influences clinical outcomes in glioma patients by regulating the cell cycle

The aggrephagy-related gene TUBA1B influences clinical outcomes in glioma patients by regulating the cell cycle

BackgroundGliomas are common primary malignant brain tumors, with glioblastoma (GBM) being the most aggressive subtype. GBM is characterized by high recurrence rates and treatment resistance, leading to poor patient outcomes. Current prognostic models have limited predictive power, underscoring the...

Full description

Bibliographic Details
Main Authors: Zesheng Sun, Pengcheng Huang, Jialiang Lin, Guiping Jiang, Jian Chen, Qianqian Liu
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-02-01
Series:Frontiers in Oncology
Subjects:
glioma
aggrephagy
TUBA1B
prognostic marker
immune microenvironment
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2025.1531465/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2025.1531465/full

Similar Items